CHRS

0.36984.47%
RA

Rita A. Karachun

Independent Director

Ms. Rita A. Karachun, CPA, CGMA, is Independent Director of Coherus Oncology, Inc. (formerly known as Coherus BioSciences, Inc.) from May 31, 2024. She is President & Director at Imago BioSciences, Inc. from January 11, 2023. She has been a Director and President of ArQule, Inc. since January 16, 2020. Ms. Karachun had been Senior Vice President of Finance and Global Controller at Merck & Co., Inc. since March 1, 2014 until December 04, 2023. Ms. Karachun serves as President & Director at Immune Design Corp. since April 02, 2019. Ms. Karachun served as Assistant Controller at Merck & Co., Inc. from November 2009 to March 1, 2014. Ms. Karachun serves as a Director at Prometheus Biosciences, Inc., since June 16, 2023. Ms. Karachun served as Assistant Controller of Schering-Plough Corporation since February 2007 and was responsible for preparing financial statements and for the worldwide consolidation of international entities. Prior to joining Merck, Ms. Karachun spent 16 years at AT&T, including serving as Assistant Controller, Chief Accountant at AT&T and as Finance Director at AT&T Capital Corp. She began her career as an auditor with Arthur Andersen LLP. Ms. Karachun currently serves on the board of Jersey Battered Women???s Services, a not-for-profit organization. She is also on advisory committees for Financial Executives International and the American Institute of Certified Public Accountants. Ms. Karachun is a graduate of Fairleigh Dickinson University. She completed her Certified Public Accountant (CPA) certification in New Jersey. She also holds a Chartered Global Management Accountant (CGMA) certification.

Positions